[go: up one dir, main page]

 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (436)

Search Parameters:
Keywords = hypothermia

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
13 pages, 2892 KiB  
Article
Administration of Adipose Tissue Derived Stem Cells before the Onset of the Disease Lowers the Levels of Inflammatory Cytokines IL-1 and IL-6 in the Rat Model of Necrotizing Enterocolitis
by Marek Wolski, Tomasz Ciesielski, Kasper Buczma, Łukasz Fus, Agnieszka Girstun, Joanna Trzcińska-Danielewicz and Agnieszka Cudnoch-Jędrzejewska
Int. J. Mol. Sci. 2024, 25(20), 11052; https://doi.org/10.3390/ijms252011052 (registering DOI) - 15 Oct 2024
Viewed by 210
Abstract
There is little research concerning the role of stem cells in necrotizing enterocolitis (NEC). Bone marrow-derived mesenchymal stem cells (BMDSC) and amniotic fluid-derived stem cells significantly reduced the amount and severity of NEC in the animal models. ADSCs share similar surface markers and [...] Read more.
There is little research concerning the role of stem cells in necrotizing enterocolitis (NEC). Bone marrow-derived mesenchymal stem cells (BMDSC) and amniotic fluid-derived stem cells significantly reduced the amount and severity of NEC in the animal models. ADSCs share similar surface markers and differentiation potential with BMDSCs. Their potential role in the setting of NEC has not been researched before. The hypothesis of the study was that prophylactic intraperitoneal administration of ADSCs before the onset of the disease will result in limiting the inflammatory response, effecting a lower incidence of NEC. On a molecular level, this should result in lowering the levels of inflammatory cytokines IL-1 and IL-6. The local ethical committee for animal experiments approval was acquired (WAW2/093/2021). We utilized a self-modified rat NEC model based on single exposure to hypothermia, hypoxia, and formula feeding. One hundred and twenty-eight rat puppies were divided into two groups—prophylaxis (ADSC-NEC, n = 66) and control group (NEC-PLCB, n = 62)—to measure the influence of ADSCs administration on the inflammatory changes in NEC, the level of cell engraftment, and the histopathology of the disease. The analysis did not show a significant effect on histopathology between groups, H(2) = 2.12; p = 0.347; η²H = 0.00. The intensity of the NEC variable results was similar across the analyzed groups (NEC-PLCB and ADSC-NEC). For IL-1 and IL-6, the difference between the NEC-PLCB group and the ADSC-NEC group was statistically significant, p = 0.002 and p < 0.001, respectively. To conclude, administration of adipose tissue-derived stem cells before the onset of the disease lowers the levels of inflammatory cytokines IL-1 and IL-6 but does not affect the histopathological results in the rat model of NEC. Full article
(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
Show Figures

Figure 1

Figure 1
<p>Levels of CD90 by group.</p>
Full article ">Figure 2
<p>Histological changes in intestinal architecture of rats with NEC. Rat bowel stained with H&amp;E showing representative sections for each morphological severity score. (<b>A</b>): normal ileum, NEC score 0. (<b>B</b>): NEC score 1, partial villous atrophy. (<b>C</b>): NEC score 2, sloughing and/or necrosis of upper parts of atrophic villi, (<b>D</b>): NEC score 3, total loss of villi and necrosis of the intestinal wall. Original magnification, 200×. Microphotographs were captured using OPTIKA LITEView software (Version: Windows x64 2.1.24744.20240303; OPTIKA, Ponteranica, Italy). Source: own materials.</p>
Full article ">Figure 3
<p>NEC intensity by group—the mean value of severity grade of all samples within each group.</p>
Full article ">Figure 4
<p>Frequency of NEC stages as defined in the grading scale (0–3) in ADSC-NEC and NEC-PLCB groups.</p>
Full article ">Figure 5
<p>Levels of IL-1 within groups.</p>
Full article ">Figure 6
<p>Levels of IL-6 within groups.</p>
Full article ">Figure 7
<p>Stem cells culture. Picture captured with light microscope Olympus ck30 (Olympus optical Co., Ltd., Tokyo, Japan), WIK10×/20 L Mangnifiation 40×. Source: own materials.</p>
Full article ">Figure 8
<p>Examples of CD90-positive cells distribution in rat bowel. (<b>A</b>): Section of colon with partial villous atrophy and only a single CD90-positive cell (marked with arrow). (<b>B</b>): Section of colon with sloughing and necrosis of upper parts of atrophic villi and scattered CD90-positive cells in mucosa and submucosa (marked with arrows). Original magnification 400×. Microphotographs were captured using OPTIKA LITEView software (Version: Windows x64 2.1.24744.20240303; OPTIKA, Ponteranica, Italy). Source: own materials.</p>
Full article ">
11 pages, 37473 KiB  
Case Report
Death by Frostbite: From Theory to Reality: A Case Report
by Stefano Duma, Federica Mele, Mariagrazia Calvano, Mirko Leonardelli, Enrica Macorano, Giovanni De Gabriele, Alessandro Cristalli, Andrea Marzullo and Francesco Introna
Forensic Sci. 2024, 4(4), 555-565; https://doi.org/10.3390/forensicsci4040037 - 11 Oct 2024
Viewed by 278
Abstract
Background: When the body temperature falls below 35 °C, a condition known as hypothermia occurs. This renders it impossible to regulate the body temperature and produce heat. In these cases, death is due to a cessation of vital functions and is triggered by [...] Read more.
Background: When the body temperature falls below 35 °C, a condition known as hypothermia occurs. This renders it impossible to regulate the body temperature and produce heat. In these cases, death is due to a cessation of vital functions and is triggered by a body temperature below 25 °C. A multidisciplinary approach is typically required when hypothermia is suspected to combine circumstantial evidence, external examination, autopsy, microscopic and biochemical findings, and other data useful to assess the diagnosis of fatal hypothermia. Post-mortem diagnosis of death by hypothermia frequently presents a medico-legal dilemma. Methods and Results: The authors present a case of hypothermia in which site inspection, autopsy, and histological examination simultaneously revealed the forensic and anatomopathological characteristic findings of hypothermia with some peculiar evidence: paradoxical undressing, thanatochronological phenomena, frost erythema, polyvisceral congestion and Wischnewski spots, and subnuclear vacuolization of renal tubular epithelial cells. Full article
Show Figures

Figure 1

Figure 1
<p>Crime scene.</p>
Full article ">Figure 2
<p>Hypostasis.</p>
Full article ">Figure 3
<p>Abrasions.</p>
Full article ">Figure 4
<p>Discoloration of hands.</p>
Full article ">Figure 5
<p>Discoloration of feet.</p>
Full article ">Figure 6
<p>Stomach with widespread reddish hemorrhagic spots.</p>
Full article ">Figure 7
<p>Pulmonary congestion.</p>
Full article ">Figure 8
<p>Micro- and macrovesicular hepatic steatosis.</p>
Full article ">Figure 9
<p>Vacuolization of the basal cells of renal tubules.</p>
Full article ">Figure 10
<p>Gastric wall with focal erosions of the mucosal surface.</p>
Full article ">Figure 11
<p>Skin with small hemorrhagic extravasations in the dermis.</p>
Full article ">
21 pages, 1412 KiB  
Review
The Crucial Triad: Endothelial Glycocalyx, Oxidative Stress, and Inflammation in Cardiac Surgery—Exploring the Molecular Connections
by Božena Ćurko-Cofek, Matej Jenko, Gordana Taleska Stupica, Lara Batičić, Antea Krsek, Tanja Batinac, Aleksandra Ljubačev, Marko Zdravković, Danijel Knežević, Maja Šoštarič and Vlatka Sotošek
Int. J. Mol. Sci. 2024, 25(20), 10891; https://doi.org/10.3390/ijms252010891 - 10 Oct 2024
Viewed by 417
Abstract
Since its introduction, the number of heart surgeries has risen continuously. It is a high-risk procedure, usually involving cardiopulmonary bypass, which is associated with an inflammatory reaction that can lead to perioperative and postoperative organ dysfunction. The extent of complications following cardiac surgery [...] Read more.
Since its introduction, the number of heart surgeries has risen continuously. It is a high-risk procedure, usually involving cardiopulmonary bypass, which is associated with an inflammatory reaction that can lead to perioperative and postoperative organ dysfunction. The extent of complications following cardiac surgery has been the focus of interest for several years because of their impact on patient outcomes. Recently, numerous scientific efforts have been made to uncover the complex mechanisms of interaction between inflammation, oxidative stress, and endothelial dysfunction that occur after cardiac surgery. Numerous factors, such as surgical and anesthetic techniques, hypervolemia and hypovolemia, hypothermia, and various drugs used during cardiac surgery trigger the development of systemic inflammatory response and the release of oxidative species. They affect the endothelium, especially endothelial glycocalyx (EG), a thin surface endothelial layer responsible for vascular hemostasis, its permeability and the interaction between leukocytes and endothelium. This review highlights the current knowledge of the molecular mechanisms involved in endothelial dysfunction, particularly in the degradation of EG. In addition, the major inflammatory events and oxidative stress responses that occur in cardiac surgery, their interaction with EG, and the clinical implications of these events have been summarized and discussed in detail. A better understanding of the complex molecular mechanisms underlying cardiac surgery, leading to endothelial dysfunction, is needed to improve patient management during and after surgery and to develop effective strategies to prevent adverse outcomes that complicate recovery. Full article
(This article belongs to the Special Issue Molecular Perspective of Cardiovascular Diseases)
Show Figures

Figure 1

Figure 1
<p>Schematic representation of the endothelial glycocalyx (EG) structure under physiological conditions. The EG covers the luminal surface of blood vessels. Some elements (glycoprotein, syndecan, and glypican) are bound to endothelial cells, while others (like heparan sulphate and chondroitin sulphate) have an indirect connection. Some molecules (like orosomucoid and albumins) are “trapped” within the matrix molecules. (ORM—orosomucoid).</p>
Full article ">Figure 2
<p>Schematic representation of EG exposed to shear stress. Note the detachment of heparan and chondroitin sulphate. Various proteases (primary matrix metalloproteinases (MMP), heparanase, and hyaluronidase) are released by activated leukocytes or induced by mechanical stress. Proteases cleave the core proteins of proteoglycans and glycoproteins in the endothelial glycocalyx, leading to their degradation. (ORM—orosomucoid).</p>
Full article ">Figure 3
<p>Inflammatory response in heart damage. This Figure represents the autophagy process in response to cardiac injury, such as ischemia, sepsis, or ischemia–reperfusion injury. Following cardiac injury, an inflammatory response is triggered, which activates the autophagy pathway. Damaged cells, including apoptotic cells, viruses, bacteria, damage-associated molecular patterns (DAMPs), and damaged mitochondria, are encapsulated in a double-membrane structure called an autophagosome. LC3-II is a marker protein involved in the formation of the autophagosome. The autophagosome then fuses with a lysosome, forming an autolysosome. The lysosomal enzymes degrade the encapsulated cell debris within the autolysosome, leading to its breakdown and recycling, thereby aiding cellular recovery and homeostasis.</p>
Full article ">
7 pages, 3277 KiB  
Case Report
A Case Report of Successful Treatment of Minoxidil Toxicosis Using Hemodialysis in a Cat
by Woonchan Ahn, Taeho Lee, Soyoung Jung and Aryung Nam
Vet. Sci. 2024, 11(10), 487; https://doi.org/10.3390/vetsci11100487 - 9 Oct 2024
Viewed by 595
Abstract
A 5-year-old castrated male American Shorthair cat presented with lethargy and anorexia after accidentally knocking over a bottle of topical minoxidil and spilling it onto its body. Physical examination revealed rapid shallow breathing, pale mucous membranes, hypothermia, tachycardia, and hypotension. Thoracic radiography revealed [...] Read more.
A 5-year-old castrated male American Shorthair cat presented with lethargy and anorexia after accidentally knocking over a bottle of topical minoxidil and spilling it onto its body. Physical examination revealed rapid shallow breathing, pale mucous membranes, hypothermia, tachycardia, and hypotension. Thoracic radiography revealed mild pulmonary infiltration and pleural effusion. Despite conservative treatment, including oxygen therapy, and intravenous fluid, furosemide, and dopamine administration, the patient showed no improvement. After two sessions of intermittent hemodialysis, the cat’s respiratory pattern and overall condition gradually improved; normal body temperature and blood pressure were achieved. The cat recovered fully and was discharged on the 11th day of hospitalization. This is the first report on the use of hemodialysis in the treatment of a cat with minoxidil toxicosis. Full article
(This article belongs to the Section Veterinary Internal Medicine)
Show Figures

Figure 1

Figure 1
<p>Thoracic radiographs on admission. (<b>A</b>) The caudal lung lobes were retracted from the thoracic wall (arrowheads). (<b>B</b>) Mild bronchointerstitial pulmonary patterns were observed.</p>
Full article ">Figure 2
<p>Thoracic radiographs taken after the second intermittent hemodialysis and before discharge. (<b>A</b>,<b>B</b>) Bilateral pleural effusions were noted with the right side being more severe. (<b>C</b>,<b>D</b>) The pleural effusions had resolved by the time of discharge.</p>
Full article ">Figure 3
<p>Echocardiogram taken after the second intermittent hemodialysis. (<b>A</b>) Right ventricular dilatation and a small amount of pericardial effusion (asterisk) in the right parasternal long-axis view. (<b>B</b>) Tricuspid regurgitation approximates 2.3 m/s (in the left apical 4-chamber view). (<b>C</b>,<b>D</b>) No abnormalities were observed in the left atrium and left ventricle.</p>
Full article ">
11 pages, 1541 KiB  
Article
Optimal Targeted Temperature Management for Patients with Post-Cardiac Arrest Syndrome
by Tsukasa Yagi, Eizo Tachibana, Wataru Atsumi, Keiichiro Kuronuma, Kazuki Iso, Satoshi Hayashida, Shonosuke Sugai, Yusuke Sasa, Yoshikuni Shoji, Satoshi Kunimoto, Shigemasa Tani, Naoya Matsumoto and Yasuo Okumura
Medicina 2024, 60(10), 1575; https://doi.org/10.3390/medicina60101575 - 25 Sep 2024
Viewed by 522
Abstract
Background: To prevent hypoxic–ischemic brain damage in patients with post-cardiac arrest syndrome (PCAS), international guidelines have emphasized performing targeted temperature management (TTM). However, the most optimal targeted core temperature and cooling duration reached no consensus to date. This study aimed to clarify [...] Read more.
Background: To prevent hypoxic–ischemic brain damage in patients with post-cardiac arrest syndrome (PCAS), international guidelines have emphasized performing targeted temperature management (TTM). However, the most optimal targeted core temperature and cooling duration reached no consensus to date. This study aimed to clarify the optimal targeted core temperature and cooling duration, selected according to the time interval from collapse to return of spontaneous circulation (ROSC) in patients with PCAS due to cardiac etiology. Methods: Between 2014 and 2020, the targeted core temperature was 34 °C or 35 °C, and the cooling duration was 24 h. If the time interval from collapse to ROSC was within 20 min, we performed the 35 °C targeted core temperature (Group A), and, if not, we performed the 34 °C targeted core temperature (Group B). Between 2009 and 2013, the targeted core temperature was 34 °C, and the cooling duration was 24 or 48 h. If the interval was within 20 min, we performed the 24 h cooling duration (Group C), and, if not, we performed the 48 h cooling duration (Group D). Results: The favorable neurological outcome rates at 30 days following cardiac arrest were 45.7% and 45.5% in Groups A + B and C + D, respectively (p = 0.977). In patients with ROSC within 20 min, the favorable neurological outcome rates at 30 days following cardiac arrest were 75.6% and 86.4% in Groups A and C, respectively (p = 0.315). In patients with ROSC ≥ 21 min, the favorable neurological outcome rates at 30 days following cardiac arrest were 29.3% and 18.2% in Groups B and D, respectively (p = 0.233). Conclusions: Selecting the optimal target core temperature and the cooling duration for TTM, according to the time interval from collapse to ROSC, may be helpful in patients with PCAS due to cardiac etiology. Full article
(This article belongs to the Special Issue Recent Advances in Cardiac Arrest)
Show Figures

Figure 1

Figure 1
<p>Therapeutic hypothermia protocols from January 2014 to December 2020. CAG indicates coronary angiography; PCI, percutaneous coronary intervention. (<b>A</b>) When the time interval from collapse to the return of spontaneous circulation (ROSC) was within 20 min, we performed the 35 °C targeted core temperature, and the cooling duration was 24 h (Group A). (<b>B</b>) When the interval was not within 20 min, we performed the 34 °C targeted core temperature, and the cooling duration was 24 h (Group B).</p>
Full article ">Figure 2
<p>Therapeutic hypothermia protocols from January 2009 to December 2013. CAG indicates coronary angiography; PCI, percutaneous coronary intervention. (<b>A</b>) When the time interval from collapse to the return of spontaneous circulation (ROSC) was within 20 min, we performed the 34 °C targeted core temperature, and the cooling duration was 24 h (Group C). (<b>B</b>) When the interval was not within 20 min, we performed the 34 °C targeted core temperature, and the cooling duration was 48 h (Group D).</p>
Full article ">Figure 3
<p>Study profile. ROSC indicates return of spontaneous circulation; CCU, cardiac care unit.</p>
Full article ">Figure 4
<p>Primary outcomes. (<b>A</b>) Whole cohort, (<b>B</b>) return of spontaneous circulation (ROSC) within 20 min, and (<b>C</b>) ROSC ≥ 21 min.</p>
Full article ">Figure 5
<p>T The favorable 30-day neurological outcomes on the basis of the time interval from collapse to return of spontaneous circulation (within 20 min, 21–30 min, and ≥31 min).</p>
Full article ">
15 pages, 927 KiB  
Review
Clinical Assessment and Management of Acute Spinal Cord Injury
by Christian Quinones, John Preston Wilson, Deepak Kumbhare, Bharat Guthikonda and Stanley Hoang
J. Clin. Med. 2024, 13(19), 5719; https://doi.org/10.3390/jcm13195719 - 25 Sep 2024
Viewed by 1191
Abstract
The information contained in this article is suitable for clinicians practicing in the United States desiring a general overview of the assessment and management of spinal cord injury (SCI), focusing on initial care, assessment, acute management, complications, prognostication, and future research directions. SCI [...] Read more.
The information contained in this article is suitable for clinicians practicing in the United States desiring a general overview of the assessment and management of spinal cord injury (SCI), focusing on initial care, assessment, acute management, complications, prognostication, and future research directions. SCI presents significant challenges, affecting patients physically, emotionally, and financially, with variable recovery outcomes ranging from full functionality to lifelong dependence on caregivers. Initial care aims to minimize secondary injury through thorough neurological evaluations and imaging studies to assess the severity of the injury. Acute management prioritizes stabilizing respiratory and cardiovascular functions and maintaining proper spinal cord perfusion. Patients with unstable or progressive neurological decline benefit from timely surgical intervention to optimize neurological recovery. Subacute management focuses on addressing common complications affecting the respiratory, gastrointestinal, and genitourinary systems, emphasizing a holistic, multidisciplinary approach. Prognostication is currently based on neurological assessments and imaging findings, but emerging biomarkers offer the potential to refine outcome predictions further. Additionally, novel therapeutic interventions, such as hypothermia therapy and neuroprotective medications are being explored to mitigate secondary damage and enhance recovery. This paper serves as a high-yield refresher for clinicians for the assessment and management of acute spinal cord injury during index admission. Full article
(This article belongs to the Section Orthopedics)
Show Figures

Figure 1

Figure 1
<p>(<b>A</b>) Patient with lower extremity motor and sensory loss after MVC (ASIA A); CT (left) and sagittal T2 MRI (middle) show T11–12 fracture dislocation; postoperative CT shows improved alignment (right). (<b>B</b>) Patient with intact sensation but no motor function after fall (ASIA B); preoperative MRI (left) shows C3–4 stenoses and cord contusion; postoperative decompression and fusion from C2–5 X-ray (right). (<b>C</b>) Patient with 2/5 hand weakness and intact sensation (ASIA C) after fall; MRI with spinal cord contusion at C4–6 (left); postoperative X-ray with instrumented decompression and fusion (right). (<b>D</b>) Patient with hand paresthesia and intact motor function after fall (ASIA D); MRI with traumatic disc herniation at C3–4 (left); postoperative C3–4 anterior cervical discectomy and fusion X-ray (right).</p>
Full article ">
15 pages, 2308 KiB  
Article
Thermoregulation Effects of Phoneutria nigriventer Isolated Toxins in Rats
by Carla Bogri Butkeraitis, Monica Viviana Abreu Falla and Ivo Lebrun
Toxins 2024, 16(9), 398; https://doi.org/10.3390/toxins16090398 - 18 Sep 2024
Viewed by 605
Abstract
Body temperature is primarily regulated by the hypothalamus, ensuring proper metabolic function. Envenomation by Phoneutria nigriventer can cause symptoms such as hypothermia, hyperthermia, sweating, and shivering, all related to thermoregulation. This study aims to analyze and identify components of the venom that affect [...] Read more.
Body temperature is primarily regulated by the hypothalamus, ensuring proper metabolic function. Envenomation by Phoneutria nigriventer can cause symptoms such as hypothermia, hyperthermia, sweating, and shivering, all related to thermoregulation. This study aims to analyze and identify components of the venom that affect thermoregulation and to evaluate possible mechanisms. Rats were used for thermoregulation analysis, venom fractionation by gel filtration and reverse-phase chromatography (C18), and sequencing by Edman degradation. The venom exhibited hypothermic effects in rats, while its fractions demonstrated both hypothermic (pool II) and hyperthermic (pool III) effects. Further separations of the pools with C18 identified specific peaks responsible for these effects. However, as the peaks were further purified, their effects became less significant. Tests on U87 human glioblastoma cells showed no toxicity. Sequencing of the most active peaks revealed masses similar to those of the Tachykinin and Ctenotoxin families, both known to act on the nervous system. The study concludes that molecules derived from venom can act synergistically or antagonistically. Additionally, toxins that affect thermoregulation are poorly studied and require further characterization. These toxins could potentially serve as sources for the development of new thermoregulatory drugs. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Variation in body temperature in rats after injection of crude <span class="html-italic">Phoneutria nigriventer</span> venom. The graph shows the average temperature variations of the control animals administered saline (IP) (n = 8) and the animals treated with 600 µg/kg (IP) of crude <span class="html-italic">Phoneutria nigriventer</span> venom (n = 6) and the temperature was measured every 15 min for 3 h. Significant values for <span class="html-italic">p</span> &lt; 0.05 (*) using a <span class="html-italic">t</span>-test between the average temperature of the control animals and the experimental animals at each point (15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 165, and 180 min).</p>
Full article ">Figure 2
<p>Fractionation of <span class="html-italic">Phoneutria nigriventer</span> venom (<b>A</b>) and body temperature variation in rats after injection of pools I, II, III, IV, and V (<b>B</b>). Body temperature variation in rats after injection of pools I, II, III, IV, and V of <span class="html-italic">Phoneutria nigriventer</span> venom, separated by gel filtration. Significant results are marked with an asterisk (*) on the graph curve. The average temperature variations of the control animals, administered intraperitoneal saline solution (n = 6), are compared with the animals administered intraperitoneally with 600 µg/kg of each pool of <span class="html-italic">Phoneutria nigriventer</span> venom, and the temperature was measured every 3 min for 3 h of the experiment. The <span class="html-italic">t</span>-test was performed between the average temperature of the control animals and each group of experimental animals at each time point (15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 165, and 180 min).</p>
Full article ">Figure 3
<p>Body temperature variation in rats after injection of peaks 8 (n = 3), 11 (n = 5), 13 (n = 5), 14 (n = 6), 17 (n = 6), and 18 (n = 5) of pool II of <span class="html-italic">Phoneutria nigriventer</span>. Significant results are marked with an asterisk (*) on the graph curve. The average temperature variations of the control animals, administered intraperitoneal saline solution (n = 4), are compared with the animals administered intraperitoneally with 100 µg/kg of each material, and the temperature was measured every 15 min during the 3 h of the experiment. Significant values for <span class="html-italic">p</span> &lt; 0.05 (*) were obtained by the <span class="html-italic">t</span>-test between the average temperature of the control animals and each group of experimental animals at each time point (15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 165, and 180 min).</p>
Full article ">Figure 4
<p>Body temperature variation in rats after injection of peaks 25 (n = 8), 26 (n = 6), 28/29 (n = 5), 30 (n = 6), and 31 (n = 6) from pool III of <span class="html-italic">Phoneutria nigriventer</span>. Significant results are marked with an asterisk (*) on the graph curve. Average temperature variations of the control animals, administered intraperitoneal saline solution (n = 6), are compared with the animals administered intraperitoneally with 100 µg/kg of material, and the temperature was measured every 15 min during the 3 h of the experiment. The <span class="html-italic">t</span>-test was performed between the average temperature of the control animals and each group of experimental animals at each time point (15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 165, and 180 min).</p>
Full article ">Figure 5
<p>The graph showing the average temperature variations of the control animals, administered intraperitoneal saline solution (n = 4), compared to the animals administered intraperitoneally with 10 µg/kg of subpeaks 13 (n = 4) from pool II and 29a (n = 5), 29b (n = 5), 29c (n = 4), 30a (n = 3), 30b (n = 4), 31a (n = 3), and 31b (n = 4) from pool III of <span class="html-italic">Phoneutria nigriventer</span>. Significant results are marked with an asterisk (*) on the graph curve. Subpeak 13 was treated with 10mg/kg of the drug Dantrolene (n = 5). The <span class="html-italic">Phoneutria nigriventer</span> subpeaks were administered at 10 µg/kg and the temperature was measured every 15 min during the 3 h of experimentation. The <span class="html-italic">t</span>-test was performed between the average temperature of the control animals and each group of experimental animals (peak 13 of pool II of <span class="html-italic">Phoneutria nigriventer</span>, Dantrolene, and peak 13 of pool II of <span class="html-italic">Phoneutria nigriventer</span> + Dantrolene) at each time point (15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 165, and 180 min).</p>
Full article ">
15 pages, 5732 KiB  
Article
Dimethyl Fumarate Strongly Ameliorates Gray and White Matter Brain Injury and Modulates Glial Activation after Severe Hypoxia–Ischemia in Neonatal Rats
by Jon Ander Alart, Antonia Álvarez, Ana Catalan, Borja Herrero de la Parte and Daniel Alonso-Alconada
Antioxidants 2024, 13(9), 1122; https://doi.org/10.3390/antiox13091122 - 16 Sep 2024
Viewed by 691
Abstract
Neonatal hypoxia–ischemia is a major cause of infant death and disability. The only clinically accepted treatment is therapeutic hypothermia; however, cooling is less effective in the most severely encephalopathic infants. Here, we wanted to test the neuroprotective effect of the antioxidant dimethyl fumarate [...] Read more.
Neonatal hypoxia–ischemia is a major cause of infant death and disability. The only clinically accepted treatment is therapeutic hypothermia; however, cooling is less effective in the most severely encephalopathic infants. Here, we wanted to test the neuroprotective effect of the antioxidant dimethyl fumarate after severe hypoxia–ischemia in neonatal rats. We used a modified Rice–Vannucci model to generate severe hypoxic–ischemic brain damage in day 7 postnatal rats, which were randomized into four experimental groups: Sham, Sham + DMF, non-treated HI, and HI + DMF. We analyzed brain tissue loss, global and regional (cortex and hippocampus) neuropathological scores, white matter injury, and microglial and astroglial reactivity. Compared to non-treated HI animals, HI + DMF pups showed a reduced brain area loss (p = 0.0031), an improved neuropathological score (p = 0.0016), reduced white matter injuries by preserving myelin tracts (p < 0.001), and diminished astroglial (p < 0.001) and microglial (p < 0.01) activation. After severe hypoxia–ischemia in neonatal rats, DMF induced a strong neuroprotective response, reducing cerebral infarction, gray and white matter damage, and astroglial and microglial activation. Although further molecular studies are needed and its translation to human babies would need to evaluate the molecule in piglets or lambs, DMF may be a potential treatment against neonatal encephalopathy. Full article
Show Figures

Figure 1

Figure 1
<p>Image analysis process used to quantify MBP expression as a subrogate of white matter injury: (<b>a</b>) original microphtograph stained with MBP immunohistochemistry; (<b>b</b>) color deconvolution photograph to retain brown color; (<b>c</b>) black and white binarized image after threshold.</p>
Full article ">Figure 2
<p>Representative images of brain sections obtained at the level of mid-dorsal hippocampus and thalamus stained with hematoxylin–eosin from Sham, Sham + DMF, non-treated HI, and HI + DMF groups.</p>
Full article ">Figure 3
<p>Global (total) and regional (cortex and hippocampus) neuropathological score values from Sham, Sham + DMF, non-treated HI, and HI + DMF groups. Maximum score values (and damage) for global, cortex, and hippocampus are 21, 12, and 9, respectively. Data were analyzed using a Kruskal–Wallis test with Dunn’s multiple comparison test. * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01; **** <span class="html-italic">p</span> &lt; 0.0001 vs. HI.</p>
Full article ">Figure 4
<p>Hemispheric and hippocampal left-to-right area ratios from Sham, Sham + DMF, non-treated HI, and HI + DMF groups. Maximum ratio value is 1. Data were analyzed using a Kruskal–Wallis test with Dunn’s multiple comparison test. ** <span class="html-italic">p</span> &lt; 0.01; **** <span class="html-italic">p</span> &lt; 0.0001 vs. HI.</p>
Full article ">Figure 5
<p>(<b>a</b>) Representative images of brain sections at the level of cingulum, external capsule, and caudoputamen stained with MBP immunohistochemistry stained in brown from Sham, non-treated HI, and HI + DMF groups; Scale bar corresponds to 100 µm. (<b>b</b>) comparison of the ipsilateral hemisphere with the contralateral hemisphere (L:R) in ratios in regional (cingulum, external capsule, and caudoputamen) sections from Sham, non-treated HI, and HI + DMF groups. Maximum ratio value is 1. Data were analyzed using a Kruskal–Wallis test with Dunn’s multiple comparison test. ** <span class="html-italic">p</span> &lt; 0.01; *** <span class="html-italic">p</span> &lt; 0.001; **** <span class="html-italic">p</span> &lt; 0.0001 vs. HI.</p>
Full article ">Figure 6
<p>(<b>a</b>) Low-magnification representative photographs of brain sections obtained at the level of mid-dorsal hippocampus and thalamus stained with GFAP immunohistochemistry from non-treated HI and HI + DMF groups; (<b>b</b>) high-magnification representative microphotographs of the morphology of GFAP-labeled astrocytic cells, showing their cytoplasm (and cellular projections) stained in brown, whereas non-astrocytic cells appear purple/blue due to hematoxylin counterstain; (<b>c</b>) regional (hippocampus, S1 cortex, perirhinal cortex, and striatum) and global (total) comparison of the amount of GFAP in pixels/µm<sup>2</sup> from non-treated HI and HI + DMF groups. Data were analyzed using a Mann–Whitney test. *** <span class="html-italic">p</span> &lt; 0.001; **** <span class="html-italic">p</span> &lt; 0.0001 vs. HI.</p>
Full article ">Figure 7
<p>(<b>a</b>) Low-magnification representative images of brain sections obtained at the level of mid-dorsal hippocampus and thalamus immunostained with Iba-1 from non-treated HI (left photograph) and HI + DMF (right photograph) groups; (<b>b</b>) high-magnification representative microphotographs of the morphology of Iba-1-labeled microglial cells, showing their cytoplasm stained in brown, whereas non-microglial cells appear purple/blue due to hematoxylin counterstain; (<b>c</b>) regional (hippocampus, S1 cortex, perirhinal cortex, and striatum) and global (total) comparison of the amount of Iba-1 in pixels/µm<sup>2</sup> from non-treated HI and HI + DMF groups. Data were analyzed using a Mann–Whitney test. ** <span class="html-italic">p</span> &lt; 0.01; *** <span class="html-italic">p</span> &lt; 0.001 vs. HI.</p>
Full article ">Figure 7 Cont.
<p>(<b>a</b>) Low-magnification representative images of brain sections obtained at the level of mid-dorsal hippocampus and thalamus immunostained with Iba-1 from non-treated HI (left photograph) and HI + DMF (right photograph) groups; (<b>b</b>) high-magnification representative microphotographs of the morphology of Iba-1-labeled microglial cells, showing their cytoplasm stained in brown, whereas non-microglial cells appear purple/blue due to hematoxylin counterstain; (<b>c</b>) regional (hippocampus, S1 cortex, perirhinal cortex, and striatum) and global (total) comparison of the amount of Iba-1 in pixels/µm<sup>2</sup> from non-treated HI and HI + DMF groups. Data were analyzed using a Mann–Whitney test. ** <span class="html-italic">p</span> &lt; 0.01; *** <span class="html-italic">p</span> &lt; 0.001 vs. HI.</p>
Full article ">
17 pages, 6642 KiB  
Review
Therapeutic Effect of Superficial Scalp Hypothermia on Chemotherapy-Induced Alopecia in Breast Cancer Survivors
by Kefah Mokbel, Alevtina Kodresko, Jon Trembley and Hussam Jouhara
J. Clin. Med. 2024, 13(18), 5397; https://doi.org/10.3390/jcm13185397 - 12 Sep 2024
Viewed by 693
Abstract
Alopecia is a common adverse effect of neoadjuvant or adjuvant chemotherapy in patients with early breast cancer. While hair typically regrows over time, more than 40% of patients continue to suffer from permanent partial alopecia, significantly affecting body image, psychological well-being, and quality [...] Read more.
Alopecia is a common adverse effect of neoadjuvant or adjuvant chemotherapy in patients with early breast cancer. While hair typically regrows over time, more than 40% of patients continue to suffer from permanent partial alopecia, significantly affecting body image, psychological well-being, and quality of life. This concern is a recognized reason why some breast cancer patients decline life-saving chemotherapy. It is critical for healthcare professionals to consider the impact of this distressing side effect and adopt supportive measures to mitigate it. Among the various strategies investigated to reduce chemotherapy-induced alopecia (CIA), scalp cooling has emerged as the most effective. This article reviews the pathophysiology of CIA and examines the efficacy of different scalp cooling methods. Scalp cooling has been shown to reduce the incidence of CIA, defined as less than 50% hair loss, by 50% in patients receiving chemotherapy. It is associated with high patient satisfaction and does not significantly increase the risk of scalp metastasis or compromise overall survival. Promising new scalp cooling technologies, such as cryogenic nitrogen oxide cryotherapy, offer the potential to achieve and maintain lower scalp temperatures, potentially enhancing therapeutic effects. Further investigation into these approaches is warranted. Research on CIA is hindered by significant heterogeneity and the lack of standardised methods for assessing hair loss. To advance the field, further interdisciplinary research is crucial to develop preclinical models of CIA, establish a uniform, internationally accepted and standardised classification system, and establish an objective, personalised prognosis monitoring system. Full article
(This article belongs to the Section Oncology)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Chemotherapy agents, risk of alopecia, and their application in breast cancer therapies and associated hair toxicity.</p>
Full article ">Figure 2
<p>Persistent chemotherapy-induced alopecia in breast cancer survivors: (<b>A</b>) diffuse alopecia 2 years after taxane-based chemotherapy completion; (<b>B</b>) persistent chemotherapy-induced alopecia 1.6 years after taxane-based chemotherapy completion with similar pattern of androgenetic alopecia and predominant hair thinning on the crown area; (<b>C</b>) trichoscopy of patient in (<b>B</b>) with miniaturized hairs, showing hair thinning and yellow dots. (<b>D</b>) Histology section showing fibrosis and mild perifollicular inflammation (hematoxylin–eosin stain) [<a href="#B9-jcm-13-05397" class="html-bibr">9</a>].</p>
Full article ">Figure 3
<p>Schematic representation of structure of hair follicle in its mature anagen phase: (<b>a</b>) a full-length longitudinal view of hair follicle; (<b>b</b>) hair follicle bulb. Abbreviations: APM, arector pili muscle; B, bulge; CTS, connective tissue sheath; CTX, cortex of hair shaft; CU, cuticle of hair shaft; DP, dermal papilla; E, epidermis; HM, hair matrix; HS, hair shaft; IRS, inner root sheath; M, melanocytes; ORS, outer root sheath; S, sebaceous gland [<a href="#B12-jcm-13-05397" class="html-bibr">12</a>].</p>
Full article ">Figure 4
<p>Normal cycle of hair growth [<a href="#B13-jcm-13-05397" class="html-bibr">13</a>].</p>
Full article ">Figure 5
<p>Molecular damage-response pathways activated by chemotherapy [<a href="#B3-jcm-13-05397" class="html-bibr">3</a>].</p>
Full article ">Figure 6
<p>Main sites where chemotherapy affects the hair cycle and generates alopecia. CT, chemotherapy [<a href="#B13-jcm-13-05397" class="html-bibr">13</a>].</p>
Full article ">Figure 7
<p>The mechanism cryotherapy affects blood flow.</p>
Full article ">Figure 8
<p>The beneficial effects of superficial scalp hypothermia in chemotherapy-induced alopecia.</p>
Full article ">Figure 9
<p>Scalp cooling devices used for chemotherapy-induced alopecia by patients with solid tumours.</p>
Full article ">Figure 10
<p>Current clinical trials [<a href="#B8-jcm-13-05397" class="html-bibr">8</a>].</p>
Full article ">Figure 11
<p>Automated scalp cooling system: a refrigeration unit (<b>A</b>) and a cooling cap (<b>B</b>) [<a href="#B25-jcm-13-05397" class="html-bibr">25</a>].</p>
Full article ">Figure 12
<p>Current evidence on scalp cooling in chemotherapy-induced alopecia in breast cancer survivors [<a href="#B28-jcm-13-05397" class="html-bibr">28</a>,<a href="#B29-jcm-13-05397" class="html-bibr">29</a>,<a href="#B30-jcm-13-05397" class="html-bibr">30</a>,<a href="#B31-jcm-13-05397" class="html-bibr">31</a>,<a href="#B32-jcm-13-05397" class="html-bibr">32</a>,<a href="#B33-jcm-13-05397" class="html-bibr">33</a>,<a href="#B34-jcm-13-05397" class="html-bibr">34</a>,<a href="#B35-jcm-13-05397" class="html-bibr">35</a>,<a href="#B36-jcm-13-05397" class="html-bibr">36</a>,<a href="#B37-jcm-13-05397" class="html-bibr">37</a>,<a href="#B38-jcm-13-05397" class="html-bibr">38</a>,<a href="#B39-jcm-13-05397" class="html-bibr">39</a>,<a href="#B40-jcm-13-05397" class="html-bibr">40</a>,<a href="#B41-jcm-13-05397" class="html-bibr">41</a>,<a href="#B42-jcm-13-05397" class="html-bibr">42</a>,<a href="#B43-jcm-13-05397" class="html-bibr">43</a>,<a href="#B44-jcm-13-05397" class="html-bibr">44</a>,<a href="#B45-jcm-13-05397" class="html-bibr">45</a>,<a href="#B46-jcm-13-05397" class="html-bibr">46</a>].</p>
Full article ">
19 pages, 863 KiB  
Review
Hypothermia for Cardioprotection in Acute Coronary Syndrome Patients: From Bench to Bedside
by Nikolaos Pyrpyris, Kyriakos Dimitriadis, Panagiotis Iliakis, Panagiotis Theofilis, Eirini Beneki, Dimitrios Terentes-Printzios, Athanasios Sakalidis, Alexios Antonopoulos, Konstantinos Aznaouridis and Konstantinos Tsioufis
J. Clin. Med. 2024, 13(18), 5390; https://doi.org/10.3390/jcm13185390 - 12 Sep 2024
Viewed by 700
Abstract
Early revascularization for patients with acute myocardial infarction (AMI) is of outmost importance in limiting infarct size and associated complications, as well as for improving long-term survival and outcomes. However, reperfusion itself may further damage the myocardium and increase the infarct size, a [...] Read more.
Early revascularization for patients with acute myocardial infarction (AMI) is of outmost importance in limiting infarct size and associated complications, as well as for improving long-term survival and outcomes. However, reperfusion itself may further damage the myocardium and increase the infarct size, a condition commonly recognized as myocardial reperfusion injury. Several strategies have been developed for limiting the associated with reperfusion myocardial damage, including hypothermia. Hypothermia has been shown to limit the degree of infarct size increase, when started before reperfusion, in several animal models. Systemic hypothermia, however, failed to show any benefit, due to adverse events and potentially insufficient myocardial cooling. Recently, the novel technique of intracoronary selective hypothermia is being tested, with preclinical and clinical results being of particular interest. Therefore, in this review, we will describe the pathophysiology of myocardial reperfusion injury and the cardioprotective mechanics of hypothermia, report the animal and clinical evidence in both systemic and selective hypothermia and discuss the potential future directions and clinical perspectives in the context of cardioprotection for myocardial reperfusion injury. Full article
(This article belongs to the Special Issue Myocardial Infarction: Current Status and Future Challenges)
Show Figures

Figure 1

Figure 1
<p>The effect of hypothermia in myocardial reperfusion injury. Abbreviations: IS: infarct size; MVO: microvascular obstruction; IMH: intramyocardial hemorrhage; AF: atrial fibrillation.</p>
Full article ">Figure 2
<p>Limitations and unanswered questions of hypothermia studies. Abbreviations: ACS: acute coronary syndrome.</p>
Full article ">
19 pages, 1165 KiB  
Review
Enhancing Neuroprotection in Cardiac and Aortic Surgeries: A Narrative Review
by Debora Emanuela Torre and Carmelo Pirri
Anesth. Res. 2024, 1(2), 91-109; https://doi.org/10.3390/anesthres1020010 - 23 Aug 2024
Viewed by 400
Abstract
Background: Neurological injury poses a significant challenge in aortic surgery, encompassing spinal cord injury from thoraco-abdominal aorta intervention or stroke post-surgery on the arch and ascending aorta. Despite ample literature and proposals, a fully effective strategy for preventing or treating neurological injury remains [...] Read more.
Background: Neurological injury poses a significant challenge in aortic surgery, encompassing spinal cord injury from thoraco-abdominal aorta intervention or stroke post-surgery on the arch and ascending aorta. Despite ample literature and proposals, a fully effective strategy for preventing or treating neurological injury remains elusive. This narrative review aims to analyze the most common neuroprotective strategies implemented for aortic arch surgery and aortic surgery. Results: Results from the reviewed studies showed that several strategies, including deep hypothermia cardiac induction (DHCA) and cerebral perfusion techniques (retrograde cerebral perfusion, RCP, and selective anterograde cerebral perfusion, SACP) aim to mitigate these risks. Monitoring methods such as electroencephalogram (EEG), somatosensory evoked potential (SEPs), and near-infrared spectroscopy (NIRS) offer valuable insights into cerebral function during surgery, aiding in the management of hypothermia and perfusion. Pharmacological agents and blood gas management (pH stat vs. alpha stat, hematocrit level, glycemic control) are crucial in preventing post-operative complications. Additionally meticulous management of atheromatous debris is essential to minimize embolic risks during surgery. Methods: For this narrative review, PubMed, Scopus, and Medline have been used to search articles about neuroprotection strategies in aortic and aortic arch surgeries. The search was narrowed to articles between 1975 and 2024. A total of 3418 articles were initially identified to be potentially relevant for this review. A total of 66 articles were included and were found to match the inclusion criteria. Conclusions: While an overabundance of neuroprotection strategies exists for cardiac surgery, particularly in procedures involving the aorta and the arch, their efficacy varies, with some well-documented and others still under scrutiny. Further research is imperative to advance our comprehension and refine prevention techniques for cardiac-surgery-related brain injury. This is crucial given its substantial contribution to both mortality and, notably, post-operative morbidity. Full article
(This article belongs to the Special Issue Anesthesia, Pain, and Monitoring: Past and Future)
Show Figures

Figure 1

Figure 1
<p>Study flow diagram.</p>
Full article ">Figure 2
<p>Risk factors for cardiac-surgery-related adverse neurological outcome.</p>
Full article ">Figure 3
<p>Cardiac-surgery-related adverse neurological outcomes, created with permission from BioRender.com.</p>
Full article ">
18 pages, 2769 KiB  
Article
Dried Blood Spot Metabolome Features of Ischemic–Hypoxic Encephalopathy: A Neonatal Rat Model
by Chupalav Eldarov, Natalia Starodubtseva, Yulia Shevtsova, Kirill Goryunov, Oleg Ionov, Vladimir Frankevich, Egor Plotnikov, Gennady Sukhikh, Dmitry Zorov and Denis Silachev
Int. J. Mol. Sci. 2024, 25(16), 8903; https://doi.org/10.3390/ijms25168903 - 15 Aug 2024
Viewed by 641
Abstract
Hypoxic–ischemic encephalopathy (HIE) is a severe neurological disorder caused by perinatal asphyxia with significant consequences. Early recognition and intervention are crucial, with therapeutic hypothermia (TH) being the primary treatment, but its efficacy depends on early initiation of treatment. Accurately assessing the HIE severity [...] Read more.
Hypoxic–ischemic encephalopathy (HIE) is a severe neurological disorder caused by perinatal asphyxia with significant consequences. Early recognition and intervention are crucial, with therapeutic hypothermia (TH) being the primary treatment, but its efficacy depends on early initiation of treatment. Accurately assessing the HIE severity in neonatal care poses challenges, but omics approaches have made significant contribution to understanding its complex pathophysiology. Our study further explores the impact of HIE on the blood metabolome over time and investigated changes associated with hypothermia’s therapeutic effects. Using a rat model of hypoxic–ischemic brain injury, we comprehensively analyzed dried blood spot samples for fat-soluble compounds using HPLC-MS. Our research shows significant changes in the blood metabolome after HIE, with a particularly rapid recovery of lipid metabolism observed. Significant changes in lipid metabolites were observed after 3 h of HIE, including increases in ceramides, carnitines, certain fatty acids, phosphocholines, and phosphoethanolamines, while sphingomyelins and N-acylethanolamines (NAEs) decreased (p < 0.05). Furthermore, NAEs were found to be significant features in the OPLS-DA model for HIE diagnosis, with an area under the curve of 0.812. TH showed a notable association with decreased concentrations of ceramides. Enrichment analysis further corroborated these observations, showing modulation in several key metabolic pathways, including arachidonic acid oxylipin metabolism, eicosanoid metabolism via lipooxygenases, and leukotriene C4 synthesis deficiency. Our study reveals dynamic changes in the blood metabolome after HIE and the therapeutic effects of hypothermia, which improves our understanding of the pathophysiology of HIE and could lead to the development of new rapid diagnostic approaches for neonatal HIE. Full article
Show Figures

Figure 1

Figure 1
<p>Study design: (<b>A</b>) HIE with sampling at different times; (<b>B</b>) modeling of therapeutic hypothermia [<a href="#B16-ijms-25-08903" class="html-bibr">16</a>].</p>
Full article ">Figure 2
<p>The dependence of time after HI exposure on the low-molecular-weight spectrum of DBS: (<b>A</b>) Principal component analysis (PCA) space based on blood compounds, whose levels show statistically significant differences in pairwise group comparisons; (<b>B</b>) Volcano plots of DBS metabolites levels over time: (<b>1</b>) 3 h after HIE, (<b>2</b>) 6 h after HIE.</p>
Full article ">Figure 3
<p>Box plots representing the concentration levels of metabolites that show significant changes over time. Plots are divided to three subgroups (<b>A</b>–<b>C</b>) to improve readability. Data are presented as mean  ±  SD. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001, **** <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 4
<p>Examples of chromatograms and mass spectrum of metabolites: (<b>A</b>) Cer P30:6;O2 (<span class="html-italic">m</span>/<span class="html-italic">z</span> 552.342); (<b>B</b>) NAE 14:4;O (<span class="html-italic">m</span>/<span class="html-italic">z</span> 302.173).</p>
Full article ">Figure 5
<p>PLS-DA score plot of DBS samples after hypoxia and therapeutic hypothermia compared to normothermia and control group.</p>
Full article ">Figure 6
<p>ROC curve for diagnosing after 3 h post-HIE based on OPLS-DA model.</p>
Full article ">
9 pages, 216 KiB  
Article
Characteristics, Outcome and Prognostic Factors of Patients with Emergency Department Cardiac Arrest: A 14-Year Retrospective Study
by Jacopo Davide Giamello, Salvatore D’Agnano, Giulia Paglietta, Chiara Bertone, Alice Bruno, Gianpiero Martini, Alessia Poggi, Andrea Sciolla and Giuseppe Lauria
J. Clin. Med. 2024, 13(16), 4708; https://doi.org/10.3390/jcm13164708 - 11 Aug 2024
Viewed by 637
Abstract
Introduction: Cardiac arrests are traditionally classified according to the setting in which they occur, including out-of-hospital cardiac arrest (OHCA) and in-hospital cardiac arrest (IHCA). However, cardiac arrests that occur in the emergency department (EDCA) could constitute a third category, due to the [...] Read more.
Introduction: Cardiac arrests are traditionally classified according to the setting in which they occur, including out-of-hospital cardiac arrest (OHCA) and in-hospital cardiac arrest (IHCA). However, cardiac arrests that occur in the emergency department (EDCA) could constitute a third category, due to the peculiar characteristics of the emergency department (ED). In recent years, the need to study EDCAs separately from other intra-hospital events has emerged. The aim of this study was to describe the characteristics and outcomes of a cohort of patients experiencing EDCA in an Italian hospital over a 14-year period. Methods: This was a single-centre retrospective observational study conducted in the ED of the Santa Croce e Carle Hospital in Cuneo, Italy. All adult patients who experienced EDCA between 1 January 2010 and 30 June 2023 were included. OHCA patients, those arriving in the ED with on-going resuscitation measures, patients with EDCA not undergoing resuscitation, and patients with post-traumatic cardiac arrest were excluded from the study. The main outcome of the study was survival at hospital discharge with a favourable neurological outcome. Results: 350 cases of EDCA were included. The median age was 78 (63–85) years, and the median Charlson Comorbidity Index score was 5 (3–6). A total of 35 patients (10%) survived to hospital discharge with a cerebral performance category (CPC) Score of 1–2; survival in the ED was 28.3%. The causes of cardiac arrests were identified in 212 cases (60.6%) and included coronary thrombosis (35%), hypoxia (22%), hypovolemia (17%), pulmonary embolism (11%), metabolic (8%), cardiac tamponade (4%), toxins (2%) and hypothermia (1%). Variables associated with survival with a favourable neurological outcome were young age, a lower Charlson Comorbidity Index, coronary thrombosis as the primary EDCA cause, and shockable presenting rhythm; however, only the latter was associated with the outcome in a multivariate age-weighted model. Conclusions: In a cohort of patients with EDCA over a period of more than a decade, the most frequent cause identified was coronary thrombosis; 10% of patients survived with a good neurological status, and the only factor associated with the best prognosis was presenting a shockable rhythm. EDCA should be considered an independent category in order to fully understand its characteristics and outcomes. Full article
(This article belongs to the Section Intensive Care)
13 pages, 1577 KiB  
Article
Impact of a ‘Catheter Bundle’ on Infection Rates and Economic Costs in the Intensive Care Unit: A Retrospective Cohort Study
by Alberto Lucchini, Marco Giani, Emanuele Rezoagli, Giulia Favata, Annagiulia Andreani, Marta Spada, Luigi Cannizzo, Nicola Barreca, Matteo Cesana, Stefano Citterio and Stefano Elli
Nurs. Rep. 2024, 14(3), 1948-1960; https://doi.org/10.3390/nursrep14030145 - 9 Aug 2024
Viewed by 1075
Abstract
Introduction: Catheter-related infections (CBRSIs) are a widespread problem that increase morbidity and mortality in intensive care unit (ICU) patients and management costs. Objective: The main aim of this study was to assess the prevalence of CBRSIs in an intensive care unit following international [...] Read more.
Introduction: Catheter-related infections (CBRSIs) are a widespread problem that increase morbidity and mortality in intensive care unit (ICU) patients and management costs. Objective: The main aim of this study was to assess the prevalence of CBRSIs in an intensive care unit following international literature guidelines for managing vascular lines in critically ill patients. These guidelines include changing vascular lines every 7 days, using needle-free devices and port protectors, standardising closed infusion lines, employing chlorhexidine-impregnated dressings, and utilising sutureless devices for catheter securement. Materials and Methods: This single-centre retrospective observational study was conducted in a general Italian ICU. This study included all eligible patients aged > 1 year who were admitted between January 2018 and December 2022. Results: During the study period, 1240 patients were enrolled, of whom 9 were diagnosed with a CRBSI. The infection rate per 1000 catheters/day was as follows: femorally inserted central catheter, 1.04; centrally inserted central catheter, 0.77; pulmonary arterial catheter 0.71, arterial catheter, 0.1; and peripherally inserted central catheter and continuous veno-venous haemodialysis dialysis catheters equal to 0. No difference in CRBSI was observed between the years included in the study (p = 0.874). The multivariate analysis showed an association between the diagnosis of CBRSI and Nursing Activities Score (per single point increase β = 0.04–95%CI: −0.01–0.09, p = 0.048), reason for ICU admission—trauma (β = 0.77–95%CI: −0.03–1.49, p = 0.039), and use of therapeutic hypothermia (β = 2.06, 95%CI: 0.51–3.20, p < 0.001). Implementing the study protocol revealed a cost of EUR 130.00/patient, equivalent to a daily cost of EUR 15.20 per patient. Conclusions: This study highlights the importance of implementing a catheter care bundle to minimise the risk of CRBSI and the associated costs in the ICU setting. A policy change for infusion set replacement every 7 days has helped to maintain the CRBSI rate below the recommended rate, resulting in significant cost reduction and reduced production of ICU waste Full article
Show Figures

Figure 1

Figure 1
<p>Infusion and monitoring lines during the study period.</p>
Full article ">Figure 2
<p>Design of the infusion line used during the study.</p>
Full article ">
13 pages, 1385 KiB  
Article
The Effect of Therapeutic Hypothermia on Ischemic Brain Injury in a Rat Model of Cardiac Arrest: An Assessment Using 18F-FDG PET
by Daehee Kim, Woon Jeong Lee, Seon Hee Woo, Hye Won Lee, Bom Sahn Kim and Hai-Jeon Yoon
Diagnostics 2024, 14(15), 1674; https://doi.org/10.3390/diagnostics14151674 - 2 Aug 2024
Viewed by 2499
Abstract
Purpose: Therapeutic hypothermia (TH) is widely acknowledged as one of the interventions for preventing hypoxic ischemic brain injury in comatose patients following cardiac arrest (CA). Despite its recognized efficacy, recent debates have questioned its effectiveness. This preclinical study evaluated the impact of TH [...] Read more.
Purpose: Therapeutic hypothermia (TH) is widely acknowledged as one of the interventions for preventing hypoxic ischemic brain injury in comatose patients following cardiac arrest (CA). Despite its recognized efficacy, recent debates have questioned its effectiveness. This preclinical study evaluated the impact of TH on brain glucose metabolism, utilizing fluorine-18-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) in a rat model of CA. Methods: Asphyxia CA was induced in Sprague-Dawley rats using vecuronium. Brain PET images using 18F-FDG were obtained from 21 CA rats, who were randomized to receive either TH or no intervention. Of these, 9 rats in the TH group received hypothermia under general anesthesia and mechanical ventilation for eight hours, while the remaining 12 rats in the non-TH group were observed without intervention. We conducted regional and voxel-based analyses of standardized uptake values relative to the pons (SUVRpons) to compare the two groups. Results: Survival rates were identical in both the TH and non-TH groups (67%). There was no discernible difference in the SUVRpons across the brain cortical regions between the groups. However, in a subgroup analysis of the rats that did not survive (n = 7), those in the TH group (n = 3) displayed significantly higher SUVRpons values across most cortical regions compared to those in the non-TH group (n = 4), with statistical significance after false-discovery rate correction (p < 0.05). Conclusions: The enhancement in SUVRpons due to TH intervention was only observed in the cortical regions of rats with severe encephalopathy that subsequently died. These findings suggest that the beneficial effects of TH on brain glucose metabolism in this asphyxia CA model may be confined to cases of severe ischemic encephalopathy. Full article
(This article belongs to the Special Issue Diagnosis and Management in Emergency Medicine)
Show Figures

Figure 1

Figure 1
<p>Flow chart of the study design. Abbreviations: CA, cardiac arrest; CPR, cardiopulmonary resuscitation; ROSC, return of spontaneous circulation; TH, therapeutic hypothermia.</p>
Full article ">Figure 2
<p>Regional distributions of SUV<sub>pons</sub> according to the TH intervention in the total group. When the analysis for the total group of 21 cardiac arrest (CA) rats was conducted, the SUVR<sub>pons</sub> across each brain cortical region showed no differences in regional distribution between the TH (<span class="html-italic">n</span> = 9) and non-TH (<span class="html-italic">n</span> = 12) groups. Data are presented as medians with interquartile ranges. Abbreviations: SUVR<sub>pons</sub>, standardized uptake value ratio normalized to pons; TH, therapeutic hypothermia.</p>
Full article ">Figure 3
<p>Regional distributions of SUV<sub>pons</sub> according to the TH intervention in survived (<b>A</b>) and non-survived (<b>B</b>) subgroups. (<b>A</b>) In the subgroup analysis of 14 survived cardiac arrest (CA) rats, the SUVR<sub>pons</sub> values across each brain cortical region exhibited no differences in regional distribution between the TH (<span class="html-italic">n</span> = 6) and non-TH (<span class="html-italic">n</span> = 8) groups. Data are presented as medians with interquartile ranges. (<b>B</b>) In the subgroup analysis of 7 non-survived CA rats, the TH group (<span class="html-italic">n</span> = 3) showed significantly higher SUVR<sub>pons</sub> than the non-TH group (<span class="html-italic">n</span> = 4) in most brain cortical regions (*, <span class="html-italic">p</span> &lt; 0.05). Data are presented as medians with interquartile ranges. Abbreviations: SUVR<sub>pons</sub>, standardized uptake value ratio normalized to pons; TH, therapeutic hypothermia.</p>
Full article ">Figure 4
<p>The statistical parametric map of “non-TH &lt; TH” in a non-survived subgroup. The statistical parametric map comparing “non-TH &lt; TH” derived from <sup>18</sup>F-FDG PET scans normalized to the pons revealed a global increase in relative glucose metabolism in TH rats within the non-survived subgroup (FDR-corrected <span class="html-italic">p</span> &lt; 0.05, <span class="html-italic">t</span> &gt; 3.3739).</p>
Full article ">
Back to TopTop